Routine annual meeting results — no earnings, guidance, or operational data. The increased share reserve for equity awards is standard and does not signal near-term dilution. Watch for EyePoint's next quarterly filing (10-Q) for pipeline updates on its drug candidates and any changes to guidance.
Price Chart
Executive Summary
EyePoint reported the results of its 2026 Annual Meeting of Stockholders held on June 18, 2026. Stockholders approved a 4,900,000-share increase to the 2023 Long-Term Incentive Plan, raising the total authorized shares to 15,300,000. All eight director nominees were elected, and the appointment of Deloitte & Touche as independent auditor was ratified. This is a routine governance filing with no financial data or unexpected changes.
Key Facts
- 4,900,000 share increase to the 2023 Long-Term Incentive Plan approved by stockholders; total authorized shares increased to 15,300,000
- All 8 director nominees were elected with ~59.8M to ~62.4M votes For each
- Quorum of 84.74% (71,010,327 of 83,795,203 shares outstanding)
- Ratification of Deloitte & Touche as independent auditor approved with 70,608,563 For vs 86,031 Against
- Say-on-pay non-binding advisory vote passed with 60,563,563 For vs 2,033,575 Against
Financial Impact
No financial results reported. The plan amendment increases equity compensation capacity by up to 4.9M shares, but no current dilution because shares require future grants and vesting.
Risk Factors
- No financial or operational data disclosed in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-276688 |
| Document: eypt-ex10_1.htm | 0001193125-26-276688 |
| Document: 0001193125-26-276688-index-headers.html | 0001193125-26-276688 |
| Document: 0001193125-26-276688-index.html | 0001193125-26-276688 |
| Document: 0001193125-26-276688.txt | 0001193125-26-276688 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.4400 $0.3657 | ▲ +16.89% | ▲ +16.74% | $0.3657 (+16.89%) |
Oct 19, 2026 7d ago | 8-K | $0.4400 $0.3707 | ▲ +15.75% | ▲ +15.61% | $0.3657 (+16.89%) |
Oct 19, 2026 7d ago | Press Release | $0.4400 $0.3657 | ▲ +16.89% | ▲ +16.74% | $0.3657 (+16.89%) |
Oct 7, 2026 19d ago | SC 13G/A | $3.32 $3.01 | ▼ −9.34% | ▼ −8.36% | $0.3657 (−88.98%) |
Sep 10, 2026 6w ago | 8-K | $4.25 $3.99 | ▼ −6.12% | ▼ −5.62% | $0.3657 (−91.40%) |
Aug 18, 2026 9w ago | Insider Buy | $6.30 $4.99 | ▼ −20.79% | ▼ −20.41% | $0.3657 (−94.20%) |
Aug 17, 2026 10w ago | 8-K | $4.87 $4.87 | · 0.00% | ▲ +1.19% | $0.3657 (−92.49%) |
Aug 5, 2026 11w ago | 8-K | $12.25 $13.53 | ▲ +10.45% | ▲ +10.10% | $0.3657 (−97.01%) |
Jul 30, 2026 12w ago | 8-K | $12.86 $12.83 | ▼ −0.23% | ▼ −3.86% | $0.3657 (−97.16%) |
Jun 22, 2026 18w ago | 8-K | $13.73 $14.11 | ▲ +2.77% | ▲ +3.22% | $0.3657 (−97.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers